The latest Brain Trauma Foundation (BTF) recommendations for the management of traumatic brain injury (TBI) indicate intracranial pressure (ICP) monitoring in patients who remain comatose after resuscitation, if the admission computed tomography (CT) scan reveals intracranial abnormalities such as haematomas, contusions and cerebral oedema [1]. This 'level 2' recommendation (moderate degree of clinical certainty) is based on the fact that such patients have a 50% risk of developing intracranial hypertension, and the assumption that intracranial hypertension is a cause of secondary brain injury amenable of treatment. Since comatose patients with normal admission CT scans have a lower risk of developing intracranial hypertension (15%) the indication for ICP monitoring in such patients is less certain; current 'level 3' (clinical certainty not established) recommendations indicate ICP monitoring in severely brain-injured patients with normal admission scans if they have added criteria of brain 'vulnerability' such as age over 40 years, systolic arterial blood pressure below 90 and motor posturing. In reality, the frequency of ICP monitoring in patients with normal admission CT scans varies greatly among centres; alternatives include early sedation holds and frequent neurological evaluations, serial CT scanning (when local facilities permit), and/or alternative, noninvasive technologies for ICP estimation such as transcranial Doppler (TCD) ultrasonography [2].
Introduction
The latest Brain Trauma Foundation (BTF) recommendations for the management of traumatic brain injury (TBI) indicate intracranial pressure (ICP) monitoring in patients who remain comatose after resuscitation, if the admission computed tomography (CT) scan reveals intracranial abnormalities such as haematomas, contusions and cerebral oedema [1] . This 'level 2' recommendation (moderate degree of clinical certainty) is based on the fact that such patients have a 50% risk of developing intracranial hypertension, and the assumption that intracranial hypertension is a cause of secondary brain injury amenable of treatment. Since comatose patients with normal admission CT scans have a lower risk of developing intracranial hypertension (15%) the indication for ICP monitoring in such patients is less certain; current 'level 3' (clinical certainty not established) recommendations indicate ICP monitoring in severely brain-injured patients with normal admission scans if they have added criteria of brain 'vulnerability' such as age over 40 years, systolic arterial blood pressure below 90 and motor posturing. In reality, the frequency of ICP monitoring in patients with normal admission CT scans varies greatly among centres; alternatives include early sedation holds and frequent neurological evaluations, serial CT scanning (when local facilities permit), and/or alternative, noninvasive technologies for ICP estimation such as transcranial Doppler (TCD) ultrasonography [2] .
Current issues in intracranial pressure management
A recent retrospective analysis reported a 43% compliance with BTF guidelines [3] . Sceptics point out that ICP-driven therapy is not devoid of complications and that ICP monitoring is not supported by randomized controlled studies [4 ] . Moreover, some authors suggest However, this 10% excess mortality in the centre that did not monitor ICP is not reflected in final results because the authors excluded patients who died in the first 24 h from the final analysis, since the study was not designed 'to investigate the potential benefit of ICP monitoring in the first 24 h after injury, for example, for the detection of rapidly expanding mass lesions needing surgical evacuation'. Although a priori survival probabilities of excluded patients were reported to be similar, it is not possible to exclude a strong exclusion bias, whereby in the centre implementing ICP monitoring a more aggressive approach leads to treatment not being withdrawn in the first day of admission despite the presence of severe injuries.
A second relevant study entitled 'Intracranial pressure monitoring in brain-injured patients is associated with worsening of survival', from Shafi et al.
[3] reports on a retrospective analysis of the National Trauma Data Bank of the period 1994-2001. Again, early deaths (<48 h) were excluded from final analysis. After controlling for markers of severity of injury and comorbidities, the authors conclude that ICP monitoring is associated with a 45% 'reduction in survival'. Whereas the reported association is of considerable interest and warrants further investigation, any inference that the act of ICP monitoring actually worsens outcome is unwise. Whereas the 45% difference in survival between the two groups is a clear finding, it is important to acknowledge that the design of the study makes it impossible to assess causality, and that the risk adjustment undertaken in the study may not have resulted in equivalent groups.
Pathophysiology in intracranial hypertension is contextsensitive
The limitations cited above apply equally to the literature supporting ICP monitoring and no randomized trial shows an outcome benefit from ICP-guided care following severe TBI [4 ] . However, ICP monitoring does have a rational physiological basis. There is good evidence that approximately 50% of patients with severe TBI and abnormal admission CT scan develop intracranial hypertension [8] , and that ICP exceeding 20 mmHg is strongly associated with mortality in TBI [1]. ICP monitoring allows diagnosis and treatment of intracranial hypertension in a timely and targeted fashion. In the absence of ICP monitoring, late increases in ICP in the sedated patient could only be detected by pupillary dilatation or the hypertension associated with a Cushing response, making early intervention impossible. [9] ; in turn, elevated intra-thoracic pressures are transmitted to the intracranial compartment, resulting in prominent ICP waves that have no adverse consequences [10, 11] . Similarly, patients undergoing cerebrospinal fluid (CSF) infusion studies develop sustained ICP waves that can exceed 40 mmHg [12] , with minimal effects on cerebral blood flow and no neurological sequelae [13] . However, the physiological compensatory mechanisms that are effective in these non-TBI individuals depend on the free circulation of CSF between the intracranial space and the spinal subarachnoid space, and on pressure-flow autoregulation, which maintains an almost constant cerebral blood flow over a wide range of CPP [14] . The exhaustion of such mechanisms is common following TBI. Trauma can cause brain oedema resulting in obliterated subarachnoid spaces, including the aqueduct and basal cisterns. When the free circulation of CSF is abolished, even moderate elevation in ICP can result in life-threatening ICP gradients and cerebral herniation, compression of vital structures, secondary brain damage and, eventually, death.
It is also important to recognize that pressure autoregulation may be severely disrupted following TBI. Disturbances of microcirculatory homeostatic mechanisms and impairment of cerebral autoregulation following TBI can result in ischaemia even in the presence of 'adequate' ICP and CPP [15] . CPP values have a clear optimal range in TBI, with worse outcomes at low or high CPP values [16] ; this optimal level of CPP may vary between patients. These observations may explain why protocols targeting a CPP above 70 mmHg following severe TBI failed to improve neurological outcome and caused a five-fold increase in adult respiratory distress syndrome [7] . Subsequent work performed by Steiner et al. [17] on the concept of individualized thresholds of 'optimal' CPP (based on cerebral vasoreactivity monitoring) demonstrated that patients managed below and above their optimal CPP tend to have worse outcome. Optimal CPP varies between patients, probably based on pretraumatic blood pressure, age and type of injury. Recent studies reinforce the point that too-low CPP and too-high CPP are detrimental [18] . Notably, driving CPP above the 'optimal' CPP threshold does not yield improvements in brain tissue oxygenation, whereas CPP below the optimal CPP threshold may result in secondary cerebral ischaemia [19 ] . Strategies for individualized 'optimization' of CPP remain to be tested in randomized clinical trials.
How to monitor intracranial pressure
Although much-needed, noninvasive technologies for ICP monitoring are being investigated, at the time of writing these remain insufficiently accurate or too cumbersome for continuous monitoring. The most reliable methods of ICP monitoring are ventricular catheters and intraparenchymal systems [20, 21] . Ventricular catheters and ICP bolts have historically been placed by neurosurgeons; however, a growing number of these devices are now being placed by neurointensivists [22] . The most common procedural complication associated with the insertion of ventricular catheters and ICP bolts is haemorrhage. Such haemorrhagic complications are in the vast majority an imaging finding of no clinical significance. Patients with a mild prolongation of International Normalised Ratio (INR) up to 1.7 have haemostatically normal levels of coagulation factors [23] and an INR 1.6 or less is considered acceptable to place a ventricular catheter following TBI [24] . Similarly, the use of fresh frozen plasma or other blood products to normalize clotting parameters before bolt insertion can delay ICP monitoring and it is not supported by available evidence [25] .
Ventricular catheters
The main advantage of ICP monitoring using an external ventricular drainage (EVD) system is that the technique allows therapeutic drainage of CSF and administration of intrathecal antibiotics. Traditional 'ventricular catheterexternal transducer' systems only allow intermittent ICP monitoring when the ventricular drain is closed. Commercially available ventricular catheters have a pressure transducer within their lumen; these systems allow simultaneous ICP monitoring and CSF drainage [26] . Ventricular catheter displacement and blockage are not uncommon. The small holes at the tip of the catheter can be obliterated by blood clots or fibrin deposits, and the catheter can become displaced so that part or all of the catheter tip sits in the brain parenchyma rather than in the ventricle. In such cases, CSF drainage will generate significant pressure gradients between the ventricular catheter lumen and the ventricles; the system will therefore grossly underestimate ICP during simultaneous ICP monitoring and ventricular CSF drainage. If a catheter obstruction is suspected, the drainage system should be kept closed until ICP reaches a steady state and an adequate CSF pulse pressure waveform is obtained, reflecting accurate ICP readings [27] . Gentle flushing with 2 ml of 0.9% NaCl can often restore the catheter patency; the procedure should be performed with the maximum attention to asepsis, as repeated manipulations of the external ventricular drainage system are associated with a higher incidence of central nervous system infections. Iatrogenic catheter-related ventriculitis and meningitis are potentially life-threatening complications caused by direct catheter contamination during introduction or by retrograde bacterial colonization of the catheter [28] . Reported infection incidences are in the range of 5% to more than 20% [29] . The use of closed drainage systems and aseptic CSF sampling and catheter flushing, and prompt removal of unneeded ventricular catheters can minimize the risk of catheter-related infections. CSF sampling may predispose to higher infection rates because of the repeated access to the drainage system; CSF sampling should therefore be indicated by specific clinical criteria rather than being routine practice. Continuous antibiotic prophylaxis is associated with a high incidence of antibiotic-resistant CSF infections and its benefits remain to be demonstrated [30, 31] . On the contrary, the use of comprehensive care bundles [32 ] or antibiotic or silver-impregnated catheters may further decrease the incidence of catheter-related CSF infections [33] [34] [35] . After removal, the catheter tip should be sent for culture, as bacterial growth is associated with a high risk of secondary meningitis, and antibiotic sensitivity testing based on microbiological analysis can guide therapy [36] .
Intraparenchymal devices
Intraparenchymal, microtransducer-tipped ICP monitors are sited in the brain parenchyma through a small burr hole and a skull bolt or a specifically designed cranial 'access device', which allows simultaneous monitoring of ICP, cerebral microdialysis and brain tissue oxygenation [37] . The preferred positioning of such devices is the nondominant frontal white matter in diffuse brain injury, or the pericontusional parenchyma in focal brain injury. Intraparenchymal pressure probes placed in the hemisphere contralateral to an intracerebral haematoma may dramatically underestimate ICP even in the case of transtentorial brain herniation [38] . Different devices are available, including fiberoptic, strain gauge, and pneumatic technologies. The pneumatic Spiegelberg ICP monitor also allows in-vivo calibration and intracranial compliance monitoring. The Neurovent-P ICP monitor is a versatile strain-gauge catheter that incorporates ICP, brain tissue oxygenation and brain temperature monitoring. Although bench testing of strain gauge ICP catheters reported excellent accuracy, recent studies raise the suspicion that zero-drift rates can be clinically significant both in the Neurovent-P [39] and the Codman monitors [40] , reinforcing the concept that ICP values should be interpreted carefully and in conjunction with clinical and radiological assessments of patients. When there is significant discrepancy between the monitored number and clinical features, re-zeroing or replacement of the ICP probe should be considered.
Intracranial pressure data acquisition and duration of intracranial pressure monitoring
The most accurate method of ICP data acquisition is continuous digital recording. Computerized recording allows time averaging, trending and the calculation of derived indexes in multimodality brain monitoring, including individualized 'optimal' CPP [41] . ICU charts reporting single end-hour ICP recordings documented by nursing staff correlate well with continuous ICP monitoring and are an acceptable alternative if computerized monitoring is not available [42] . Episodic events such as increased intra-thoracic pressure due to ventilator asynchronization can elevate instantaneous ICP. Even in the case of manual ICP recording, averaging over at least 10 min is mandatory in order to prevent undue administration of ICP-lowering treatments. ICP monitoring is continued as long as clinically indicated, based on the individual time course of ICP and neurological recovery. A recent study investigated the time course of ICP following TBI; onethird of TBI patients developed intracranial hypertension a week after injury [43] . In the sub-acute phase, ICPlowering therapies are cautiously withdrawn in a sequential manner and sedation stopped to assess neurological recovery. In this phase, a stable ICP over a period of 24 h warrants removal of the ICP monitoring device. Episodic spikes in ICP due to coughing or suctioning manoeuvres may not reflect exhaustion of the intracranial volumebuffering reserve, and responding to such events may unnecessarily prolong invasive ICP monitoring. In such cases, it is good practice to obtain a CT head demonstrating resolved brain oedema and no space occupying lesions with mass effect before removing the ICP monitoring device. Nonconvulsive electrographic seizures are a common complication that can result in delayed vasogenic increase in ICP, cerebral metabolic derangement and poor neurological status [44] . The suspicion of nonconvulsive seizures raised by vasogenic ICP waves in the context of normal CT appearances should be confirmed by electroencephalographic (EEG) studies and treated according to serial EEG findings and neurological recovery.
What to do with the number
Although critical values of ICP ('herniation' pressure) may vary between individual patients and in time after injury, the current consensus is to treat ICP exceeding the 20 mmHg threshold [45] . However, some interventions that effectively lower ICP may worsen brain metabolic state [46] . The main advantage of continuous ICP monitoring is that it prevents blind prophylactic treatment of ICP, avoiding unnecessary administration of ICP-lowering therapies. Modern metabolic monitoring may allow us to use these therapies in a rational way that optimizes ICP management in individual patients [47] . Moreover, labile ICP requiring increased therapeutic aggressiveness is often a sign of intracranial volumebuffering reserve exhaustion. ICP monitoring not only guides medical treatment, but also triggers prompt imaging and timely evacuation of space-occupying lesions, preventing surgical delays and secondary brain injury.
Future prospects
Advanced, computerized morphological analysis of the ICP pulse-waveform using the Morphological Cluster and Analysis of Intracranial Pressure (MOCAIP) algorithm showed that ICP monitoring might be extended to provide an indicator of global cerebral perfusion. Qualitatively, it was observed that elevation of the third peak of the ICP pulse-waveform is associated with low cerebral blood flow as assessed by Xenon perfusion studies. ICP pulse-waveform analysis using MOCAIP metrics showed a sensitivity of 93% and a specificity of 85% for the detection of cerebral hypoperfusion using a threshold of 20 ml/min/100 g [48] . This promising waveform-analysis technology remains to be tested in prospective clinical studies.
Another important research topic relates to the development of noninvasive ICP monitors. Different technologies are being tested. Tympanic membrane displacement [49] and ultrasound 'time of flight' [50] can determine temporal ICP changes within patients; yet they remain poor surrogates of invasive ICP measurements. Several recent studies suggest that measurements of the optic sheath diameter using transorbital ultrasound or magnetic resonance imaging may provide useful noninvasive estimates of ICP [51, 52] . More recently, a technique based on raising intraocular pressure to the point at which the central retinal vein is observed to collapse (venous ophthalmodynamometry) showed the possibility of measuring absolute ICP with good accuracy [53] . The prototype still needs to be validated for safety and applicability in the clinical scenario on a larger cohort of critically ill patients with increased ICP. TCD ultrasonography can provide a relatively accurate and clinically applicable noninvasive estimate of ICP and CPP [54] . However, continuous monitoring of ICP with TCD technology is prone to artefacts, as TCD probes become easily displaced even by small movements of the patient (i.e. during nursing manoeuvres). The need of a dedicated technician to guarantee adequate positioning of the TCD probes makes the technique too cumbersome for continuous monitoring. Recently, a new methodology that allows the identification of the minimum arterial blood pressure warranting adequate cerebral perfusion without the need for ICP monitoring has been introduced. The technology is based on the use of a noninvasive cerebral oximeter and it is of diagnostic value especially in patients for whom direct ICP monitoring is not feasible or indicated [56] . The index was used to identify the lower limit of cerebral autoregulation in patients undergoing cardiopulmonary bypass [57 ] . Validation on larger cohorts of severely brain-injured patients will be required to demonstrate the applicability of this methodology in the care of severe TBI.
Conclusion
Following severe TBI, approximately 50% of patients with abnormal admission CT scan develop intracranial hypertension. Although noninvasive ICP estimation using TCD has a role as a screening tool for intracranial hypertension in selected patients, ICP is best monitored invasively, with ventricular drains or intraparenchymal monitors. The current consensus is to treat ICP exceeding the 20 mmHg threshold and to maintain CPP between 50 and 70 mmHg. Multimodality brain monitoring allows further fine-tuning of cerebral perfusion based on individual changes in brain physiology.
